by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Diamond-Herpanacine of PA, Inc. Warning Letter Details

Warning Letter

Diamond-Herpanacine of PA, Inc.

Diamond-Herpanacine of PA, Inc., 1518 Grove Avenue Jenkintown , PA 19046-2302 United States

Issue DateJanuary 22, 2026

FEI NumberN/A

Violations1

CountryUnited States

Issuing Office

Human Foods Program

Product Type

Dietary Supplements

Status

Open

Subject

New Drug/Misbranded

Diamond-Herpanacine of PA, Inc. FDA Warning Letter, January 22, 2026